Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Bone Neoplasms × olaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 18 Ovarian Neoplasms 12 Neoplasm Metastasis 9 Prostatic Neoplasms 8 Neoplasms 8 Pancreatic Neoplasms 7 Triple Negative Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Advanced Solid Tumors 4 Small Cell Lung Carcinoma 3 Recurrence 3 Head and Neck Neoplasms 3 Fallopian Tube Neoplasms 3 Solid Tumors 2 Sarcoma 2 Neuroendocrine Tumors 2 Lymphoma 2 Hodgkin Disease 2 Fanconi Anemia, Complementation Group D1 2 Endometrial Neoplasms 2 Carcinoma, Squamous Cell 2 Advanced Solid Tumours 2 Advanced Solid Tumor 2 Triple Negative Metastatic Breast Cancer 1 Thymoma 1 Thrombocytosis 1 Solid Tumor 1 Smoking 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1

Interventions

pembrolizumab 2 Radiotherapy 2 Radiation 2 Gemcitabine 2 Etoposide 2 Doxorubicin 2 Cyclophosphamide 2 Cryotherapy 2 Cryosurgery 2 tocilizumab 1 selinexor 1 robatumumab 1 poly ICLC 1 olaparib 1 montanide ISA 51 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 flt3 ligand protein 1 eltrombopag 1 cc-486 1 Vincristine 1 Trabectedin 1 Temozolomide 1 Radiotherapy, Intensity-Modulated 1 Leukapheresis 1 Irinotecan 1 Interleukin-2 1 Injections 1 Imiquimod 1 Ifosfamide 1 Denosumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02398058 2021-04-14

TOMAS

Italian Sarcoma Group

Phase 1 Completed

Bone Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡